AI in Healthcare

The FDA just opened a 48-hour comment window on its draft guidance for regulating generative AI medical devices. This move signals the agency’s intent to bring clarity, but could it slow innovation in diagnostics? A new AI model has already shown promise in detecting early signs of Alzheimer’s disease—how does the regulatory path ahead affect such advancements? Source: https://news.google.com/rss/articles/CBMiggFBVV95cUxQMDJQQlZ1N2t0U3VvMVc2SVdoSzE2LWljTFdIbnQzLTc1TEZyUVJGXzNLZDM2eTJaeENRTUFzcUZpd2RDMUZpQVBYenVnRmJKQWs0X2pVbnQ0UEJJQzZUQXdzSVhPS3k3MGt6ZFAwUXhGbGJZXzJUaTNSanNCMXg1bDFn?oc=5 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III Director, ALEX Companies; Associate Broker, Alexander Tiffany Southwest, LLC. +1 713.918.9951 · [email protected]